Xu Zheng, Chuo Jing, Zhao Xiaoqin
Taiyuan University of Technology, Taiyuan, China.
Taiyuan University of Technology, Taiyuan, China
BMJ Open. 2025 Jan 4;15(1):e086013. doi: 10.1136/bmjopen-2024-086013.
This study aimed to assess the effect of home-based exercise interventions on walking performance in patients with peripheral artery disease (PAD) and intermittent claudication (IC).
Systematic review and meta-analysis.
We searched the Medline, Web of Science, Embase, Scopus and Cochrane Library databases to identify randomised controlled trials of patients with PAD and IC published in English up to August 2024.
Randomised controlled trials of patients who participated in home-based exercise interventions and were assessed for walking performance were eligible for inclusion. Studies without available data were excluded.
We analysed the pooled effect size on walking performance based on the standardised mean differences between groups. A leave-one-out sensitivity analysis was performed to ensure the robustness of the findings.
A total of eight studies were included in the meta-analysis. The duration of interventions in the included studies ranged from 6 to 52 weeks. In the pooled analysis, compared with control groups, the home-based exercise intervention groups showed improved pain-free walking distance (standardised mean difference 0.67, 95% CI 0.20 to 1.15), and maximal walking distance (0.47, 0.05 to 0.89). The overall heterogeneity score of pain-free walking distance was I=83% (p<0.001), and for maximal walking distance, I=78% (p<0.001).
Home-based exercise interventions for patients with PAD and IC were beneficial in improving pain-free walking distance and maximal walking distance. Future studies should consider multiple factors that may affect the effectiveness of home training and intervention compliance.
PROSPERO, CRD42024499020.
本研究旨在评估居家运动干预对周围动脉疾病(PAD)和间歇性跛行(IC)患者步行能力的影响。
系统评价和荟萃分析。
我们检索了Medline、科学网、Embase、Scopus和Cochrane图书馆数据库,以识别截至2024年8月以英文发表的关于PAD和IC患者的随机对照试验。
参与居家运动干预并接受步行能力评估的患者的随机对照试验符合纳入标准。无可用数据的研究被排除。
我们根据组间标准化均值差异分析了步行能力的合并效应量。进行了逐一剔除敏感性分析以确保研究结果的稳健性。
荟萃分析共纳入八项研究。纳入研究的干预持续时间为6至52周。在汇总分析中,与对照组相比,居家运动干预组的无痛步行距离(标准化均值差异0.67,95%置信区间0.20至1.15)和最大步行距离(0.47,0.05至0.89)有所改善。无痛步行距离的总体异质性评分I=8۳%(p<0.001),最大步行距离的异质性评分I=7۸%(p<0.001)。
针对PAD和IC患者的居家运动干预有助于改善无痛步行距离和最大步行距离。未来的研究应考虑可能影响家庭训练效果和干预依从性的多种因素。
PROSPERO,CRD420244990۲۰。